🇺🇸 FDA
Patent

US 8058295

Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof

granted A61KA61K31/426A61K31/655

Quick answer

US patent 8058295 (Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof) held by The Regents of the University of California expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/426, A61K31/655, A61P, A61P43/00